Clopidogrel Versus Dipyridamole in Addition to Aspirin in Reducing Embolization Detected With Ambulatory Transcranial Doppler
Open Access
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 42 (3) , 650-655
Abstract
Background and Purpose—: After stroke and transient ischemic attack there is a high early risk of recurrent stroke, particularly in large artery disease. It has been suggested more intensive antiplatelet regimens are required, but trial data are lacking. Treatment efficacy can be evaluated using transcranial Doppler detection of embolic signals. Ambulatory transcranial Doppler has recently been developed; prolonged recording may reduce subject numbers required to determine therapeutic efficacy. In a randomized trial (ISRCTN68019845) with blinded end point evaluation, we determined whether treatment with dipyridamole or clopidogrel, in addition to aspirin, was more effective at reducing embolization. Methods—: Consecutive patients with recent symptomatic carotid stenosis were recruited. Ambulatory transcranial Doppler and platelet aggregometry were performed at baseline and 48 hours. Patients, all on aspirin, were randomized to dipyridamole or clopidogrel. Recordings were analyzed offline masked to subject identity. Results—: Sixty patients were recruited, 30 in each arm. The primary end point of change in embolic signal frequency did not differ between groups ( P =0.36). In patients with embolic signals at baseline, there was no difference in reduction in embolic signal frequency: dipyridamole (75.5; SD 17.7%) versus clopidogrel (77.5; SD 20.5%; P =0.77). Baseline platelet aggregation was not different between regimens, but at 48 hours, adenosine 5′-diphosphate aggregation rate (but not collagen) was lower with clopidogrel ( P <0.001). Conclusions—: Both dipyridamole and clopidogrel reduced embolization to a similar extent. Embolic signals are strong predictors of future stroke rate in this patient group. Our results suggest these 2 treatment regimens have similar efficacy in early secondary prevention of stroke, although this now needs testing in large Phase III trials.Keywords
This publication has 18 references indexed in Scilit:
- Doppler Embolic Signals in Cerebrovascular Disease and Prediction of Stroke RiskStroke, 2009
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokeNew England Journal of Medicine, 2008
- Recent advances in management of transient ischaemic attacks and minor ischaemic strokesThe Lancet Neurology, 2006
- Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic strokePlatelets, 2006
- Ambulatory Transcranial Doppler Cerebral Embolic Signal Detection in Symptomatic and Asymptomatic Carotid StenosisStroke, 2005
- Asymptomatic Embolization Detected by Doppler Ultrasound Predicts Stroke Risk in Symptomatic Carotid Artery StenosisStroke, 2005
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- Long-Term Ambulatory Monitoring for Cerebral Emboli Using Transcranial Doppler UltrasoundStroke, 2004
- Consensus on Microembolus Detection by TCDStroke, 1998
- Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model.Stroke, 1993